Compare Hims and Hers Health Inc (HIMS) vs Workiva Inc (WK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hims and Hers Health Inc vs Workiva Inc — how do they compare? Hims and Hers Health Inc trades at $29.98 (market cap $7.12B), while Workiva Inc trades at $68.07 (market cap $3.76B). The key difference: Hims and Hers Health Inc is the larger of the two by market cap, and Workiva Inc is trading nearer its 52-week high, Hims and Hers Health Inc nearer its low. Which is the better fit depends on your goals.
| HIMS | WK | |
|---|---|---|
Market Cap | $7.12B | $3.76B |
Sector | Health | Technology |
52-Week High | $62.76 | $93.31 |
52-Week Low | $14.52 | $44.31 |
Enterprise Value | $7.82B | $3.73B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HIMS stock trades at $29.97, down 5.67% amid mixed Q2 2026 results. Revenue growth remains strong with a 2026 outlook raised to $3.1B-$3.3B, but profitability is pressured by margin compression and a net loss. Technical indicators are neutral to bearish, with support near $29. Recent news highlights an FTC investigation and class-action lawsuits adding uncertainty.
The outlook is cautious. Growth prospects from AI and global expansion are offset by significant margin challenges and regulatory risks. Analyst consensus is a Hold with a $33 price target, suggesting limited near-term upside amid execution and profitability concerns.
Workiva (WK) trades at $68.07, up 1.11% today, with strong technical momentum and bullish moving averages. The company has delivered three consecutive quarterly earnings beats, with Q2 2026 revenue of $255 million exceeding guidance. Analyst sentiment remains overwhelmingly positive with 16 buy ratings and a $69 consensus target. The stock shows robust revenue growth but elevated valuation multiples with a P/E of 82.2.
Outlook remains constructive given consistent earnings outperformance and strong subscription growth, though high valuation and negative net income in 2025 present risks. The company's AI platform expansion and Fortune 500 customer base support long-term growth potential, but investors should monitor profitability improvement and competitive pressures in the compliance software space.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →About Workiva Inc
Workiva is a leading provider of cloud-based platforms for complex reporting and compliance. It enables organizations to connect and manage data across financial reporting, ESG (Environmental, Social, and Governance), and GRC (Governance, Risk, and Compliance), serving as a single source of truth for auditable, transparent disclosures to regulators and stakeholders.
Read more on WK →
